This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Morgan Stanley analyst Betsy Graseck downgraded the rating for Bank of America Corporation BAC from Overweight to Equal-Weight but raised the price target from $48 to $55. Bank of America shares closed at $46.75 on Friday. See how other analysts view this stock.
Leerink Partners analyst Puneet Souda downgraded Myriad Genetics, Inc. MYGN from Outperform to Market Perform and slashed the price target from $30 to $21. Myriad Genetics shares closed at $15.13 on Friday. See how other analysts view this stock.
Jefferies analyst Michael Yee downgraded the rating for Biogen Inc. BIIB from Buy to Hold and lowered the price target from $250 to $180. Biogen shares closed at $157.78 on Friday. See how other analysts view this stock.
B of A Securities analyst Vivek Arya downgraded Advanced Micro Devices, Inc. AMD from Buy to Neutral and lowered the price target from $180 to $155. AMD shares closed at $138.59 on Friday. See how other analysts view this stock.
JP Morgan analyst Sandeep Deshpande downgraded the rating for STMicroelectronics N.V. STM from Overweight to Neutral. STMicroelectronics shares closed at $26.43 on Friday. See how other analysts view this stock.